RENALYTIX SP.ADS/2
RENALYTIX SP.ADS/2 operates in various business sectors.
RENALYTIX SP.ADS/2 (2O9A) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, RENALYTIX SP.ADS/2 (2O9A) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
RENALYTIX SP.ADS/2 - Net Assets Trend (None–None)
This chart illustrates how RENALYTIX SP.ADS/2's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for RENALYTIX SP.ADS/2 (None–None)
The table below shows the annual net assets of RENALYTIX SP.ADS/2 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to RENALYTIX SP.ADS/2's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
RENALYTIX SP.ADS/2 Competitors by Market Cap
The table below lists competitors of RENALYTIX SP.ADS/2 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Orchard Funding Group PLC
LSE:ORCH
|
$1.51K |
|
Nasdaq Global Travel and Leisur
STU:A4E1
|
$1.51K |
|
Nicolas Miguet et Associes SA
PA:MLNMA
|
$1.51K |
|
CONVERTIS
BE:LAH1
|
$1.51K |
|
Arno Therapeutics
OTCGREY:ARNI
|
$1.50K |
|
Spirits Time International Inc
PINK:SRSG
|
$1.50K |
|
Amper SA
MU:APR
|
$1.50K |
|
Mix1 Life Inc
PINK:MIXX
|
$1.50K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in RENALYTIX SP.ADS/2's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares RENALYTIX SP.ADS/2's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently RENALYTIX SP.ADS/2 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares RENALYTIX SP.ADS/2's net assets metrics with peer companies in the same industry.
No peer company data available for comparison.